LivingFuture

/livingfuture

  hello@livingfuture.com
  support@livingfuture.com
  (800) 975-1741

Copyright © 2025 LivingFuture.
All rights reserved.
An Architech company.
Powered by _Core.
Support by BPXI/O.

March 2018 AJP Editor Spotlight: Cannabidiol as an Adjunctive Therapy in Schizophrenia

March 2018 AJP Editor Spotlight: Cannabidiol as an Adjunctive Therapy in Schizophrenia

March 2018 AJP Editor Spotlight: Cannabidiol as an Adjunctive Therapy in Schizophrenia

American Journal of Psychiatry Deputy Editor Daniel S. Pine, M.D., discusses an article titled "Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial" by Philip McGuire, F.R.C.Psych., F.Med.Sci., and colleagues.